Australasian Journal of Dermatology最新文献

筛选
英文 中文
A reply to: 'Melanoma documented arising in an involuting naevus 3 years after cessation of monitoring'. 答复在停止监测 3 年后,在内陷痣中发现黑色素瘤 "的回复。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-05 DOI: 10.1111/ajd.14382
Miranda Wallace, Jim Muir
{"title":"A reply to: 'Melanoma documented arising in an involuting naevus 3 years after cessation of monitoring'.","authors":"Miranda Wallace, Jim Muir","doi":"10.1111/ajd.14382","DOIUrl":"https://doi.org/10.1111/ajd.14382","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population-based case-control study. 关于患有良性前列腺增生(BPH)和雄激素性脱发(AGA)的非那雄胺使用者患精神障碍的风险:一项基于人群的病例对照研究。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-04 DOI: 10.1111/ajd.14380
Keng Chen, Samuel Zagarella
{"title":"Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population-based case-control study.","authors":"Keng Chen, Samuel Zagarella","doi":"10.1111/ajd.14380","DOIUrl":"https://doi.org/10.1111/ajd.14380","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin-17 inhibitors for the management of severe rosacea. 白细胞介素-17抑制剂用于治疗重度酒渣鼻。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-04 DOI: 10.1111/ajd.14377
Sera Sarsam, Dédée F Murrell
{"title":"Interleukin-17 inhibitors for the management of severe rosacea.","authors":"Sera Sarsam, Dédée F Murrell","doi":"10.1111/ajd.14377","DOIUrl":"https://doi.org/10.1111/ajd.14377","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diversifying dermatology: Improving skin of colour representation. 皮肤病学多样化:改善有色人种皮肤的代表性。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-07-24 DOI: 10.1111/ajd.14356
Alyssa Susanto, Vaishnavi Nathan, Monika Janda, Kiarash Khosrotehrani, Erin McMeniman, H Peter Soyer, Brigid Betz-Stablein
{"title":"Diversifying dermatology: Improving skin of colour representation.","authors":"Alyssa Susanto, Vaishnavi Nathan, Monika Janda, Kiarash Khosrotehrani, Erin McMeniman, H Peter Soyer, Brigid Betz-Stablein","doi":"10.1111/ajd.14356","DOIUrl":"10.1111/ajd.14356","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141750973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vulvovaginal lichen planus mimicking desquamative inflammatory vulvovaginitis: A case series. 模拟脱屑性炎症性外阴阴道炎的外阴阴道扁平苔藓:病例系列。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-07-04 DOI: 10.1111/ajd.14344
Marlene Wijaya, Rebecca Bronwyn Saunderson, Gayle Fischer
{"title":"Vulvovaginal lichen planus mimicking desquamative inflammatory vulvovaginitis: A case series.","authors":"Marlene Wijaya, Rebecca Bronwyn Saunderson, Gayle Fischer","doi":"10.1111/ajd.14344","DOIUrl":"10.1111/ajd.14344","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermoscopic features of the normal vermilion in skin of colour. 有色皮肤正常朱砂的皮肤镜特征。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-06-18 DOI: 10.1111/ajd.14336
Biswanath Behera, Sonika Garg, Vishal Thakur, Shreya K Gowda, Priyanka Sangwan
{"title":"Dermoscopic features of the normal vermilion in skin of colour.","authors":"Biswanath Behera, Sonika Garg, Vishal Thakur, Shreya K Gowda, Priyanka Sangwan","doi":"10.1111/ajd.14336","DOIUrl":"10.1111/ajd.14336","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141417590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JAK inhibitors in refractory dermatomyositis: A case series. JAK 抑制剂治疗难治性皮肌炎:病例系列
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-06-18 DOI: 10.1111/ajd.14335
L Corbella-Bagot, X Bosch-Amate, E Gimeno-Ribes, J Gil-Lianes, P Giavedoni, J C Milisenda, S Prieto-González, R Hurtado García, J M Mascaró
{"title":"JAK inhibitors in refractory dermatomyositis: A case series.","authors":"L Corbella-Bagot, X Bosch-Amate, E Gimeno-Ribes, J Gil-Lianes, P Giavedoni, J C Milisenda, S Prieto-González, R Hurtado García, J M Mascaró","doi":"10.1111/ajd.14335","DOIUrl":"10.1111/ajd.14335","url":null,"abstract":"<p><p>This retrospective cohort study assessed the efficacy and safety of Janus kinase (JAK) inhibitors, tofacitinib and baricitinib, in 14 patients with refractory dermatomyositis (DM), a multisystemic autoimmune disorder with limited therapeutic options. Results demonstrated a significant median decrease of 21 points and a 76% reduction in the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) scores, along with a complete resolution of muscular symptoms in 64% of the patients. JAK inhibitors were effective in managing refractory DM across various subtypes with mild and manageable adverse events.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141417592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to adalimumab in Caucasian and Asian patients with hidradenitis suppurativa: A retrospective cohort study of an Australian cohort stratified by patient-reported ethnicity. 高加索人和亚裔化脓性扁桃体炎患者对阿达木单抗的反应:一项按患者报告的种族分层的澳大利亚队列回顾性队列研究。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-06-25 DOI: 10.1111/ajd.14343
James Pham, Akshay Flora, Lauren Guttman, Timothy Allan, Nisha Suyien Chandran, John W Frew
{"title":"Response to adalimumab in Caucasian and Asian patients with hidradenitis suppurativa: A retrospective cohort study of an Australian cohort stratified by patient-reported ethnicity.","authors":"James Pham, Akshay Flora, Lauren Guttman, Timothy Allan, Nisha Suyien Chandran, John W Frew","doi":"10.1111/ajd.14343","DOIUrl":"10.1111/ajd.14343","url":null,"abstract":"<p><strong>Background/objectives: </strong>Caucasian and Asian patients with hidradenitis suppurativa demonstrate significant differences with regard to age, gender and body mass index. Demographic characteristics are known to influence the efficacy and drug survival of hidradenitis suppurativa therapeutics including biologic therapies. What remains unknown is the impact of ethnicity upon the efficacy of therapeutics once demographic and disease characteristics have been taken into account. This is an important question given the expansion of biologic therapies for HS into the global patient community.</p><p><strong>Methods: </strong>We assessed 170 patients from a single HS specialist centre in Australia stratified by patient-identified ethnicity including those identifying as either Caucasian or Asian.</p><p><strong>Results: </strong>Asian patients demonstrated lower BMI, higher rates of smoking and greater odds of Hurley stage 3 disease with tunnels than Caucasian patients in line with the reported literature. There was no significant difference between percentage of individuals achieving HiSCR50 or IHS4-55 at Week 16. Significant differences were seen in median time to secondary loss of response, and Kaplan-Meier curve analysis showed a significant difference between curves when stratified by patient-reported ethnicity. Cox regression analysis demonstrated after accounting for age, gender, BMI, smoking and Hurley stage, the significance of ethnicity in influencing time to secondary loss of response disappears.</p><p><strong>Conclusions: </strong>Caucasian or Asian ethnicity does not influence response to adalimumab treatment on patients with hidradenitis suppurativa.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141454952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of biologic drugs in children or adolescents with atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials. 生物制剂药物对儿童或青少年特应性皮炎患者的安全性和疗效:随机对照试验的系统回顾和荟萃分析。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-08-05 DOI: 10.1111/ajd.14358
Ana Clara Felix de Farias Santos, Fernanda Valeriano Zamora, Lorhayne Kerly Capuchinho Scalioni Galvao, Nicole Dos Santos Pimenta, João Pedro Costa Esteves Almuinha Salles, Kélen Klein Heffel
{"title":"Safety and efficacy of biologic drugs in children or adolescents with atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials.","authors":"Ana Clara Felix de Farias Santos, Fernanda Valeriano Zamora, Lorhayne Kerly Capuchinho Scalioni Galvao, Nicole Dos Santos Pimenta, João Pedro Costa Esteves Almuinha Salles, Kélen Klein Heffel","doi":"10.1111/ajd.14358","DOIUrl":"10.1111/ajd.14358","url":null,"abstract":"<p><p>Children and adolescents suffering from moderate-to-severe atopic dermatitis (AD) face a significant disease burden that greatly impacts their quality of life. Treatment options for AD are currently limited. To assess the safety and efficacy of biologic drugs, dupilumab, lebrikizumab, or tralokinumab, in improving outcomes in patients with moderate to severe inadequately controlled AD. We searched PubMed, Embase and Cochrane databases for randomized controlled trials (RCTs) comparing dupilumab, lebrikizumab or tralokinumab to placebo in patients with AD. We computed odds ratios (ORs) for binary endpoints, with 95% confidence intervals (CIs), random effects model was used and a p-value <0.05 was considered as statistically significant. We analysed data into Review Manager 5.4. A total of five RCTs and 973 patients were included, of whom 592 were prescribed a biologic drug. Compared with placebo, patients receiving a biologic drug had a greater improvement, achieved an Investigator Global Assessment (IGA) score of 0 or 1 (OR 5.05; 95% CI 3.08-8.29), Eczema Area and Severity Index (EASI) 75 (OR 6.87; 95% CI 4.71-10.02), EASI 50 (OR 8.89; 95% CI 6.18-12.78) and EASI 90 (8.30; 95% CI 4.81-14.31). The proportion of patients with 3 points or more (OR 6.56; 95% CI 4.34-9.90) or 4 points or more (OR 8.09; 95% CI 5.19-12.59) improvement from baseline in peak pruritus NRS was significantly higher with biologic drugs than placebo. There were no significant differences between groups regarding adverse events (OR 0.79; 95% CI 0.58-1.07), and conjunctivitis (OR 2.08; 95% CI 1.00-4.33). In this meta-analysis, dupilumab, lebrikizumab, and tralokinumab have shown significant improvements in signs, symptoms and quality of life in children or adolescents with moderate to severe AD. Larger studies may be needed to continue evaluating the safety and efficacy of these biologic drugs in this patient population.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta-blockers for the treatment of infantile haemangiomas in premature infants. β-受体阻滞剂治疗早产儿婴儿血管瘤。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2024-11-01 Epub Date: 2024-06-24 DOI: 10.1111/ajd.14338
Lynn Chua Ting Ling, Mark Koh Jean Aan
{"title":"Beta-blockers for the treatment of infantile haemangiomas in premature infants.","authors":"Lynn Chua Ting Ling, Mark Koh Jean Aan","doi":"10.1111/ajd.14338","DOIUrl":"10.1111/ajd.14338","url":null,"abstract":"<p><p>Beta-blockers have been established as a treatment of infantile haemangiomas (IH) since its serendipitous discovery for use in IH in 2008. However, data on the safety of these beta-blockers for use in IH in preterm infants are scarce. A retrospective study was performed to review the safety of oral propranolol and topical timolol in the treatment of IH in a cohort of preterm infants treated at our tertiary paediatric hospital. It was observed that there was an increased risk of adverse events amongst the preterm infants with chronic lung disease, retinopathy of prematurity and gastroesophageal reflux, when treated with oral propranolol.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141454949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信